Home | Stago

In the world

Stago Group Companies

sthemE Qualiris Our International External Quality Assessment (EQA) program for Hemostasis organized by a Proficiency Testing provider accredited to the ISO 17043 standard.

My Expert QC My Expert QC was designed as part of a process of continuous improvement of quality control management. It enables users to compare their internal quality control results with those of their peers on any instrument of the STA range.

Stago webinars Stago provides you with the latest information regarding new tests, new markers or key assays for Thrombosis and Hemostasis. These educational sessions are provided by healthcare professionals and international key opinion leaders in the field.

Our Products & Services

Your new customer area, now available!

Your new customer area, now available!

For over 10 years, you have had access to your own special Customer area. As part of our desire to bring you more digital services, Stago is now launching My Personal Space, a new customer portal tailored to your new needs.

The newest additions to Stago’s Max Generation, intelligently designed to

The newest additions to Stago’s Max Generation are intelligently designed to meet the needs of today’s laboratories.

Setting the standard with exclusive mechanical technology built into all Stago systems for more than 30 years, Stago’s Viscosity-Based Detection System consistently delivers the right result, the first time.

My Expert QC, a new web application for comparing internal quality controls

My Expert QC, a new web application for comparing internal quality controls

Following on from its internal and external quality controls (My Daily QC and My Qualiris QC, respectively), Stago has supplemented its quality control offer by launching My Expert QC, a connected platform dedicated solely to the external comparison of quality controls.

Health Economics Outcomes evaluation of Stago D-dimer

Health Economics Outcomes evaluation of Stago D-dimer

Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.

Stago proposes a solution for diagnosing Von Willebrand disease: STA-VWF:RCo*

Stago proposes a solution for diagnosing Von Willebrand disease: STA-VWF:RCo*

Von Willebrand disease is a bleeding disorder resulting from a qualitative or quantitative deficiency of the von Willebrand factor (VWF).

Breaking News

Stago Webinar available on-demand!

Le Webinar Stago est disponible "à la demande" !

The newest additions to Stago’s Max Generation are intellige…

The newest additions to Stago’s Max Generation are intelligently designed to meet the needs of today’s laboratories.

Stago continues to ditch paper!

La dématérialisation continue chez Stago !

D-Dimer for the Exclusion of Thromboembolism (DiET) Study Co…

D-Dimer for the Exclusion of Thromboembolism (DiET) Study Completed STA® - Liatest® D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

Stago continues to ditch paper!

La dématérialisation continue chez Stago !

Stago in
Canada

Stago Canada Ltd/Ltée (SCL) is the exclusive provider of the Diagnostica Stago Hemostasis product lines in Canada and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Stago Canada Ltd./Ltée. is Canadian subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products.

Our Action

Our Action, Stago values

Events

No item in the list.

Careers

Browse Open Job

Mobile Applications

iHemostasis

Download our iHemostasis application to explore more about the fundamentals of hemostasis science and management.

All about Hemostasis

Haemoscore

With this interactive application, you can now access useful Scores and Algorithm recognised by the scientific community on demand
www.haemoscore.com

Useful Scores and Algorithm